A014570 Stock Overview
Manufactures and sells medicines for treating various diseases in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Korean Drug Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,785.00 |
| 52 Week High | ₩7,980.00 |
| 52 Week Low | ₩4,095.00 |
| Beta | 0.099 |
| 1 Month Change | 4.13% |
| 3 Month Change | -2.35% |
| 1 Year Change | -30.04% |
| 3 Year Change | -41.79% |
| 5 Year Change | -42.97% |
| Change since IPO | 139.25% |
Recent News & Updates
Recent updates
Unpleasant Surprises Could Be In Store For Korean Drug Co., Ltd.'s (KOSDAQ:014570) Shares
Jun 19
Should You Be Adding Korean Drug (KOSDAQ:014570) To Your Watchlist Today?
Mar 11Korean Drug (KOSDAQ:014570) Is Growing Earnings But Are They A Good Guide?
Feb 19
Korean Drug Co., Ltd.'s (KOSDAQ:014570) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01Is Korean Drug Co., Ltd. (KOSDAQ:014570) Popular Amongst Insiders?
Jan 11Can You Imagine How Jubilant Korean Drug's (KOSDAQ:014570) Shareholders Feel About Its 111% Share Price Gain?
Dec 24Here's Why I Think Korean Drug (KOSDAQ:014570) Might Deserve Your Attention Today
Dec 06Are Korean Drug's (KOSDAQ:014570) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 18Shareholder Returns
| A014570 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | -0.7% |
| 1Y | -30.0% | 10.0% | -5.5% |
Return vs Industry: A014570 underperformed the KR Pharmaceuticals industry which returned 11.5% over the past year.
Return vs Market: A014570 underperformed the KR Market which returned -2.2% over the past year.
Price Volatility
| A014570 volatility | |
|---|---|
| A014570 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in KR Market | 12.9% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A014570 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A014570's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | n/a | Hai Park | www.nicepharma.com |
Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd.
Korean Drug Co., Ltd. Fundamentals Summary
| A014570 fundamental statistics | |
|---|---|
| Market cap | ₩52.21b |
| Earnings (TTM) | -₩389.58m |
| Revenue (TTM) | ₩74.41b |
0.7x
P/S Ratio-134.0x
P/E RatioIs A014570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A014570 income statement (TTM) | |
|---|---|
| Revenue | ₩74.41b |
| Cost of Revenue | ₩38.02b |
| Gross Profit | ₩36.39b |
| Other Expenses | ₩36.78b |
| Earnings | -₩389.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -35.70 |
| Gross Margin | 48.91% |
| Net Profit Margin | -0.52% |
| Debt/Equity Ratio | 0% |
How did A014570 perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yieldn/a
Payout RatioDoes A014570 pay a reliable dividends?
See A014570 dividend history and benchmarks| Korean Drug dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 07 2025 |
| Days until Ex dividend | 37 days |
| Days until Dividend pay date | 64 days |
Does A014570 pay a reliable dividends?
See A014570 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 19:00 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Korean Drug Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|